In recent years, the tumor-stroma ratio (TSR) has attracted increasing attention as an independent prognostic factor for several solid tumors. However, the importance of the stromal compartment has not been investigated yet in gallbladder cancer (GBC). The objective of this study is to investigate the prognostic value of TSR in GBC and the relationship between TSR and other known prognostic parameters. A total of 51 patients who underwent operations for gallbladder carcinoma were selected for this study. TSR was determined on haematoxylin and eosin (H&E)-stained sections by two independent investigators. Stromal ratio groups were classified as stroma-poor (ratio of stroma < 50%) and stroma-rich (ratio of stroma >50%). The Mann-Whitney test, the Chi-squared test, the Kaplan-Meier method, and the Cox proportional hazards model were used to analyze the data. The median survival time for patients in the stroma-rich group was 6.00 months (95% CI, 4.47-7.54). In contrast, for the stroma-poor group, the median survival time was 17.00 months (95% CI, 3.64-30.36). The 3-year overall survival rate was 19.7% in the stroma-poor group and 7.2% in the stroma-rich group. Patients with stromarich tumors had a worse prognosis than those with stroma-poor tumors (log-rank P = 0.004). According to the univariate analysis, the TSR, differentiation grade, pTNM stage, and operative methods were shown to be related to overall survival (OS) with statistical significance. The hazard ratio (HR) of TSR was 2.428 (95% CI, 1.29-4.58; P = 0.006). However, the TSR did not prove to be an independent prognostic factor in the multivariate analysis. Our study demonstrated that the tumor-stroma ratio (TSR) is an important prognostic parameter for gallbladder cancer (GBC). Stroma-rich tumors were associated with poor overall survival.
Gallbladder cancer (GBC) is an uncommon malignancy in the majority of cancer patients worldwide, but it is the most prevalent and aggressive malignancy of the biliary tract. It is a highly lethal disease and its overall 5-year survival rate does not exceed 5% [1] . Regional nodal status and the depth of tumor invasion (T status) are the two most important prognostic factors for GBC. The histological subtype of gallbladder cancer is another important prognostic factor [2] . Currently, R0 surgical resection is the only curative treatment for GBC. Treatment of the cancer mainly depends on its clinical stage and the characteristics of the tumor cells. However, patients diagnosed at the same stage often have markedly different prognoses. Current research needs to investigate additional prognostic markers. The stromal compartment of tumors may provide valuable information about such markers. Through continuous paracrine communication, the tumor stromal compartment, consisting of fibroblasts, pericytes, leukocytes, endothelial cells, and extracellular matrix [ECM] , plays an important part in tumor initiation, growth, and progression [3] . In GBC however, the importance of the stromal compartment has not been investigated.
In recent years, the components of the tumor stroma have attracted growing attention as independent prognostic factors for several solid tumors. Previous studies evaluated patients with stroma-rich tumors who were found to have a worse prognosis in cases of colon carcinoma [4] , hepatocellular carcinoma [5] , early cervical carcinoma [6] , breast cancer [7] , and epithelial ovarian cancer [8] . We hypothesize that the tumor-stroma ratio (TSR) may also be an important prognostic factor for GBC. Since the prognostic value of the TSR has not been explored for GBC, we aimed to investigate the prognostic value of TSR in GBC, as well as the relationship between TSR and other known prognostic parameters.
Patients and methods

Patients.
A total of 51 patients who underwent operations for gallbladder carcinoma at the Qingdao Municipal Hospital between January 2008 and December 2013 were selected for this study. Th ese operations included radical operations, cholecystectomy, and palliative resection. Patients who were treated with pre-operative chemotherapy or radiotherapy were excluded, since these procedures can infl uence the evaluation of TSR. We used patient medical records to obtain clinical information such as gender, age, pathology type, diff erentiation grade, UICC T-stage, UICC N-stage, UICC M-stage, pTNM stage, surgical margin, and operative methods.
Histopathological scoring. Tissue samples obtained from the Department of Pathology included haematoxylin and eosin (H&E)-stained sections. Th e most invasive region of the GBC tumor on each section was analyzed using a 4× objective. Th e stroma and tumor were then analyzed using a 10× objective. Only areas where both stroma and tumor we re present with tumor cells found at all the borders of the image fi eld were scored, in order to avoid scoring peripheral regions at the edge of the tumor. In cases of tumor heterogeneity, stro ma-rich areas were associated with a worse prognosis and therefore considered decisive. In general, stroma-rich areas were found near areas of deepest microscopic infi ltration. If the stroma tissue did not contain tumor cells, it was not thought to be related to the tumor. Th e assessment was performed by analyzing at least one microscopic fi eld. Th e estimate was recorded as the TSR. With this protocol, two investigators independently estimated the tumor-stroma ratio in a blinded manner (per tenfold: 10, 20, 30%, etc.). When the two observers diff ered from each other, a third pathologist was consulted. A 50% cut-off value was established as described by Mesker and colleagues [4] . Str omal ratio groups were stratifi ed as stroma-poor: ratio of stroma < 50% and stroma-rich: ratio of stroma >50% (Figure 1) .
Follow-up. Follow-up data were collected until December 2015 or death. All patients were followed regularly aft er their operations. Overall survival (OS) was defi ned as the interval between the date of operation and date of death or the time of the last follow-up. Patients who were alive at the last time of follow-up were classifi ed as cens ored observations. Statistical analysis. Statistical analysis was performed using the statistical package SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). Th e associations between TSR and other clinicopathological parameters were investigated using the Mann-Whitney test and the Chi-squared test, respectively, for continuous variables and categorical variables. Th e Cohe n's kappa coeffi cient was used to assess intra-observer variability. All cases of death irrelevant to GBC were censored. Th e survival curves were analyzed via the Kaplan-Meier method. Th e log rank test was used to assess the diff erences between the groups for statistical signifi cance. Th e Cox proportional hazards model was used to determine the hazard ratio (HR) and 95% confi dence intervals (CIs) of variables for OS in univariate and multivariate analysis. Only thos e variables with statistical signifi cance in univariate analysis were included in multivariate analysis. All statistical tests were 2-sided, and P<0.05 was considered to be statistically signifi cant.
Results
Patients and clinicopathological features.
A total of 51 patients with gallbladder cancer were included in this study, with exclusion of samples involving poor histological quality, incomplete patient information, and failure of follow-up. Th e median age of the 51 patients was 61 years (range, 40-81) at the time of surgery. 48 patients were diagnosed with adenocarcinoma, 2 patients with squamous cell carcinomas, and 1 patient with adenosquamous carcinoma. Haematoxylin and eosin (H&E)-stained sections from the most invasive part of the tumor were microscopically assessed for stromal percentages using a 10x objective. We observed areas with a size as large as one microscopic field (10x objective, 100x total magnification), as well as larger areas matching 2-4 fields, independent of the size of the tumor. The estimate of TSR was obtained and the kappa value was 0.85, indicating good agreement between the two investigators. All inconsistent cases involved those with stromal percentages of 40-60%. 19 cases (37.3%) were scored as stroma-high and 32 cases (62.7%) were scored as stroma-low.
Association between TSR and clinicopathological features. The associations between TSR and other clinicopathological parameters were analyzed using the Mann-Whitney test for continuous variables and the Chi-squared test for categorical variables. Based on the TSR, all 51 patients were separated into a stroma-rich group (n = 19) and a stroma-poor group (n = 32). Survival and multivariate analysis. A Kaplan-Meier curve was used to analyze the relationship between OS and tumorstroma ratio, which was statistically significant (log-rank P = 0.004, Figure 2 ). Patients with stroma-rich tumors had a worse prognosis than those with stroma-poor tumors. The median survival time for patients in the stroma-rich group was 6.00 months (95% CI, 4.47-7.54). In contrast, for the stroma-poor group, the median survival time was 17.00 months (95% CI, 3.64-30.36). The 3-year overall survival rate was 19.7% in the stroma-poor group and 7.2% in the stroma-rich group.
The relationship between OS and all clinicopathological characteristics was investigated using the Cox univariate model. The TSR, differentiation grade, pTNM stage, and operative methods were identified as significant indicators for the OS rate. As shown in Table 2 , the HR of TSR was 2.428 (95% CI, 1.287-4.582; P =0.006). Parameters with statistical significance in the univariate analysis were included in the multivariate analysis. With the Cox multivariate analysis, only operative methods were identified as an independent prognostic factor of OS. The HR of TSR was 1.323 (95% CI, 0.552-3.171; P = 0.530; Table 2 ). Although TSR was not an independent prognostic factor for the OS rate, it was still a significant indicator for survival.
Discussion
Our study demonstrated that the tumor-stroma ratio (TSR) is an important prognostic parameter for gallbladder cancer (GBC). Patients with stroma-rich tumors had a worse prognosis than those with stroma-poor tumors. TSR has been shown to be a prognostic factor for GBC in previous studies. Mesker et al.
were the first to demonstrate that the tumor-stroma ratio (TSR) was an independent prognostic factor for colon cancer [4, 9] , while Huijbers et al. found that a high percentage of stromal involvement was associated with a poor prognosis.
The 5-year overall survival (OS) and disease-free survival (DFS) rates were 69.0% and 58.6% versus 83.4%and 77.3% for stroma-high versus stroma-low groups, respectively [10] . Similar results can be seen in cases of hepatocellular carcinoma [5] , early cervical carcinoma [6] , epithelial ovarian cancer [8] , and breast cancer [7] . Our study showed that the median survival time for patients in the stroma-rich group was 6.00 months (95% CI, 4.47-7.54). In contrast, for the stroma-poor group, the median survival time was 17.00 months (95% CI, 3.64-30.36). The 3-year overall survival rate was 19.7% in the stroma-poor group and 7.2% in the stroma-rich group. To our knowledge, the most important prognostic factors for GBC are regional nodal status, the depth of tumor invasion (T status), and the histological subtype. All these factors were analyzed in our study. TSR was significantly associated with UICC T-stage (P=0.02). According to the univariate analysis, the TSR, differentiation grade, pTNM stage, and operative methods were shown to be related to OS with statistical significance. TSR might be an important prognostic parameter for gallbladder cancer. However, the TSR was not identified as an independent prognostic factor in the multivariate analysis. The most likely reason was that our study was a relatively small retrospective study of 51 patients. Moreover, this outcome could be partly explained by the difference among several histological types of GBC, which leads to different effects of the standard prognostic variables. Further researches need to be done. The determination of TSR involves a simple and convenient procedure of routine pathological examination using standard H&E sections. The repeatability of evaluation of the TSR was also adequate. The Cohen's kappa coefficient was 0.85, indicating good agreement between the two independent investigators. Similar conclusions were reached in previous studies of cervical carcinoma (kappa value 0.87) [6] and breast cancer (kappa value 0.80) [7] . Because of its convenience, rapid, and inexpensiveness in clinical application, TSR could be a useful tool for facilitating the collection of prognostic information of GBC. In addition, the interactions between stromal components and tumors are critical for tumor aggressiveness and thus must be seriously considered for future novel therapeutic approaches [11] . There are several theories that could explain the relationship between stroma-rich tumors and poor overall survival. It is well known that endocrine, paracrine, and cell-cell interactions between the tumor microenvironment (TME) and the tumor contribute to tumor growth. The tumor microenvironment (TME) contains cells of the immune system, fibroblasts, and adipocytes, as well as blood and lymphatic vessels, and regulates many processes such as wound healing and inflammation [12] . The tumor microenvironment (TME) can potentially influence disease prognosis and is likely an important prognostic factor for several reasons. First, the location, density, and phenotype of the different immune cells, as well as secreted chemokines and cytokines, indicate 'immune contexture' which has prognostic significance [13] . Mononuclear phagocytes are classified into two main types: classically activated macrophages (M1) and alternatively activated macrophages (M2). M1-and M2-polarized macrophages display a number of distinct features. Ma et al. showed that M1 macrophage infiltration is linked to better survival [14] , whereas M2 macrophage infiltration is associated with a poor prognosis [15, 16] . The balance between the different populations of lymphocytes guides the pro or anti-tumorigenic nature of the inflammatory response [17] . PD-L1 expressed by tumoral cells inhibits the immunosuppressive functions of T cells by ligation with their membrane protein PD-1. PD-L1 expression has also been linked with a worse prognosis in many patients with tumors [18] . Secondly, it has been hypothesized that a higher proportion of reactive stroma could increase the tumor burden by producing more growth factors. Altered levels of TGF-β, a main mediator of communication between the tumor and its micro-environment, can cause cancer progression by stimulation of angiogenesis, tumor immune escape, and recruitment of myofibroblasts [19] . Moreover, secreted protein acidic and rich in cysteine (SPARC), a matricellular protein that promotes the interaction between tumor cells and substrates, was reported to be strongly expressed in the stroma cells of pancreatic adenocarcinoma, non-small cell lung cancer, and colorectal carcinoma [20] [21] [22] . Changes in the stroma could thus promote the invasion and metastasis of tumors. Thirdly, cancer-associated fibroblasts (CAFs) play an important role in tumor progression by producing various growth factors, angiogenic factors, inflammatory factors, and ECM proteins [23] . Fibroblasts can promote angiogenesis through the secretion of growth factors, cytokines, and extracellular matrix proteins to facilitate the processes of tumor growth and progression [24, 25] . For example, Orimo et al. found that cancer-associated fibroblasts promote angiogenesis, tumor growth, and immune cell recruitment [26] . In addition, it has been suggested that the relative amount of desmoplastic fibrosis may help the tumor to escape from immunosurveillance [27] by its encapsulation of the malignant cells to prevent any damage [28] . Hence, the communication between the tumor and its micro-environment is a complex process, and it should be recognized that the tumor stroma plays key roles in progression and invasion of GBC. Furthermore, the interaction between cancer cells and stromal cells in the tumor microenvironment may be useful for the screening of potential candidate markers for GBC in the development of future cancer therapies [29] .
In conclusion, the tumor-stroma ratio (TSR) can provide prognostic information for gallbladder cancer (GBC) patients. Stroma-rich tumors were associated with poor overall survival. Since the determination of TSR is simple, readily available, and low cost, TSR may serve as a novel prognostic histological characteristic in gallbladder cancer patients. In recent years, the tumor microenvironment has attracted increasing attention in scientific research, because of its important role in tumor invasion and metastasis. Future studies will aim to find new therapeutic targets in the tumor microenvironment.
